Financhill
Sell
43

ITW Quote, Financials, Valuation and Earnings

Last price:
$240.34
Seasonality move :
2.29%
Day range:
$236.68 - $241.96
52-week range:
$214.66 - $279.13
Dividend yield:
2.46%
P/E ratio:
21.14x
P/S ratio:
4.52x
P/B ratio:
21.75x
Volume:
1.5M
Avg. volume:
1.4M
1-year change:
-2.76%
Market cap:
$70.5B
Revenue:
$15.9B
EPS (TTM):
$11.37
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $12.6B $14.5B $15.9B $16.1B $15.9B
Revenue Growth (YoY) -10.88% 14.96% 10.22% 1.1% -1.3%
 
Cost of Revenues $7.4B $8.5B $9.4B $9.3B $8.9B
Gross Profit $5.2B $6B $6.5B $6.8B $7B
Gross Profit Margin 41.35% 41.27% 40.82% 42.16% 44.28%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.2B $2.4B $2.6B $2.6B $2.7B
Other Inc / (Exp) $11M $39M $233M -$2M $397M
Operating Expenses $2.3B $2.5B $2.7B $2.8B $2.8B
Operating Income $2.9B $3.5B $3.8B $4B $4.3B
 
Net Interest Expenses $189M $190M $181M $215M $239M
EBT. Incl. Unusual Items $2.7B $3.3B $3.8B $3.8B $4.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $595M $632M $808M $866M $934M
Net Income to Company $2.1B $2.7B $3B $3B $3.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.1B $2.7B $3B $3B $3.5B
 
Basic EPS (Cont. Ops) $6.66 $8.55 $9.80 $9.77 $11.75
Diluted EPS (Cont. Ops) $6.63 $8.51 $9.77 $9.74 $11.71
Weighted Average Basic Share $316.9M $315.1M $309.6M $302.6M $296.8M
Weighted Average Diluted Share $318.3M $316.4M $310.7M $303.6M $297.8M
 
EBITDA $3.3B $3.9B $4.5B $4.5B $5.1B
EBIT $2.9B $3.5B $4B $4.1B $4.7B
 
Revenue (Reported) $12.6B $14.5B $15.9B $16.1B $15.9B
Operating Income (Reported) $2.9B $3.5B $3.8B $4B $4.3B
Operating Income (Adjusted) $2.9B $3.5B $4B $4.1B $4.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $3.5B $3.9B $4B $4B $3.8B
Revenue Growth (YoY) 9.79% 11.15% 2.03% -1.15% -3.37%
 
Cost of Revenues $2B $2.4B $2.3B $2.1B $2.2B
Gross Profit $1.5B $1.6B $1.7B $1.8B $1.7B
Gross Profit Margin 42.47% 40.16% 41.75% 46.01% 43.71%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $566M $652M $675M $676M $706M
Other Inc / (Exp) $12M $14M $10M $16M $12M
Operating Expenses $600M $687M $706M $701M $727M
Operating Income $905M $895M $972M $1.1B $951M
 
Net Interest Expenses $52M $48M $60M $71M $68M
EBT. Incl. Unusual Items $865M $861M $922M $1.1B $895M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $194M $199M $208M $253M $195M
Net Income to Company $671M $662M $714M $819M $700M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $671M $662M $714M $819M $700M
 
Basic EPS (Cont. Ops) $2.12 $2.12 $2.34 $2.74 $2.39
Diluted EPS (Cont. Ops) $2.11 $2.11 $2.33 $2.73 $2.38
Weighted Average Basic Share $316.6M $312.5M $305M $298.9M $293.6M
Weighted Average Diluted Share $317.9M $313.7M $306.1M $300M $294.5M
 
EBITDA $1B $1B $1.1B $1.2B $1.1B
EBIT $917M $909M $982M $1.1B $963M
 
Revenue (Reported) $3.5B $3.9B $4B $4B $3.8B
Operating Income (Reported) $905M $895M $972M $1.1B $951M
Operating Income (Adjusted) $917M $909M $982M $1.1B $963M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $12.9B $14.9B $16B $16.1B $15.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $7.5B $8.8B $9.4B $9.1B $8.9B
Gross Profit $5.3B $6B $6.6B $6.9B $6.9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.2B $2.4B $2.6B $2.6B $2.7B
Other Inc / (Exp) -$2M $41M $229M $4M $393M
Operating Expenses $2.3B $2.6B $2.7B $2.7B $2.8B
Operating Income $3B $3.5B $3.9B $4.2B $4.1B
 
Net Interest Expenses $190M $186M $193M $226M $236M
EBT. Incl. Unusual Items $2.8B $3.3B $3.9B $4B $4.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $620M $637M $817M $911M $876M
Net Income to Company $2.2B $2.7B $3.1B $3.1B $3.4B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.2B $2.7B $3.1B $3.1B $3.4B
 
Basic EPS (Cont. Ops) $7.00 $8.55 $10.03 $10.17 $11.41
Diluted EPS (Cont. Ops) $6.97 $8.51 $10.00 $10.14 $11.37
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $3.5B $3.9B $4.5B $4.6B $4.9B
EBIT $3B $3.5B $4.1B $4.3B $4.5B
 
Revenue (Reported) $12.9B $14.9B $16B $16.1B $15.8B
Operating Income (Reported) $3B $3.5B $3.9B $4.2B $4.1B
Operating Income (Adjusted) $3B $3.5B $4.1B $4.3B $4.5B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $3.5B $3.9B $4B $4B $3.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2B $2.4B $2.3B $2.1B $2.2B
Gross Profit $1.5B $1.6B $1.7B $1.8B $1.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $566M $652M $675M $676M $706M
Other Inc / (Exp) $12M $14M $10M $16M $12M
Operating Expenses $600M $687M $706M $701M $727M
Operating Income $905M $895M $972M $1.1B $951M
 
Net Interest Expenses $52M $48M $60M $71M $68M
EBT. Incl. Unusual Items $865M $861M $922M $1.1B $895M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $194M $199M $208M $253M $195M
Net Income to Company $671M $662M $714M $819M $700M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $671M $662M $714M $819M $700M
 
Basic EPS (Cont. Ops) $2.12 $2.12 $2.34 $2.74 $2.39
Diluted EPS (Cont. Ops) $2.11 $2.11 $2.33 $2.73 $2.38
Weighted Average Basic Share $316.6M $312.5M $305M $298.9M $293.6M
Weighted Average Diluted Share $317.9M $313.7M $306.1M $300M $294.5M
 
EBITDA $1B $1B $1.1B $1.2B $1.1B
EBIT $917M $909M $982M $1.1B $963M
 
Revenue (Reported) $3.5B $3.9B $4B $4B $3.8B
Operating Income (Reported) $905M $895M $972M $1.1B $951M
Operating Income (Adjusted) $917M $909M $982M $1.1B $963M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $2.6B $1.5B $708M $1.1B $948M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.5B $2.8B $3.2B $3.1B $3B
Inventory $1.2B $1.7B $2.1B $1.7B $1.6B
Prepaid Expenses $30M $71M $52M $55M $60M
Other Current Assets $119M $140M $175M $157M $147M
Total Current Assets $6.5B $6.4B $6.3B $6.2B $5.9B
 
Property Plant And Equipment $2B $2B $2.1B $2.2B $2.3B
Long-Term Investments -- -- -- -- --
Goodwill $4.7B $5B $4.9B $4.9B $4.8B
Other Intangibles $781M $972M $768M $657M $592M
Other Long-Term Assets $737M $718M $715M $771M $804M
Total Assets $15.6B $16.1B $15.4B $15.5B $15.1B
 
Accounts Payable $534M $585M $594M $581M $519M
Accrued Expenses $658M $719M $780M $755M $738M
Current Portion Of Long-Term Debt $350M $568M $537M $1.4B $777M
Current Portion Of Capital Lease Obligations $55M $61M $55M $58M $57M
Other Current Liabilities -- -- $1M -- --
Total Current Liabilities $2.6B $3.5B $4.5B $4.7B $4.3B
 
Long-Term Debt $7.8B $6.9B $6.2B $6.3B $6.3B
Capital Leases -- -- -- -- --
Total Liabilities $12.4B $12.5B $12.3B $12.5B $11.8B
 
Common Stock $6M $6M $6M $6M $6M
Other Common Equity Adj -$1.6B -$1.5B -$1.8B -$1.8B -$1.9B
Common Equity $3.2B $3.6B $3.1B $3B $3.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1M $1M $1M $1M $1M
Total Equity $3.2B $3.6B $3.1B $3B $3.3B
 
Total Liabilities and Equity $15.6B $16.1B $15.4B $15.5B $15.1B
Cash and Short Terms $2.6B $1.5B $708M $1.1B $948M
Total Debt $8.1B $7.7B $7.8B $8.2B $7.9B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $2.5B $1.3B $1.1B $959M $873M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.7B $3.1B $3.2B $3.2B $3.2B
Inventory $1.3B $1.9B $2B $1.8B $1.7B
Prepaid Expenses -- -- -- -- --
Other Current Assets $266M $377M $334M $349M $348M
Total Current Assets $6.7B $6.7B $6.7B $6.4B $6B
 
Property Plant And Equipment $1.7B $1.8B $1.9B $2B $2.1B
Long-Term Investments -- -- -- -- --
Goodwill $4.6B $5B $4.9B $4.9B $4.9B
Other Intangibles $747M $875M $738M $653M $572M
Other Long-Term Assets $1.3B $1.4B $1.2B $1.3B $1.4B
Total Assets $15.7B $16.3B $15.9B $15.7B $15.5B
 
Accounts Payable $589M $696M $599M $597M $594M
Accrued Expenses $1.3B $1.5B $1.5B $1.5B $1.5B
Current Portion Of Long-Term Debt $350M -- $542M $666M --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- $1M -- --
Total Current Liabilities $2.7B $3.9B $5.6B $4.8B $3.8B
 
Long-Term Debt $7.6B $6.8B $5.5B $6.3B $7.3B
Capital Leases -- -- -- -- --
Total Liabilities $12.4B $12.7B $12.8B $12.6B $12.2B
 
Common Stock $6M $6M $6M $6M $6M
Other Common Equity Adj -$1.6B -$1.5B -$1.8B -$1.9B -$1.9B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2M $1M $1M $1M $1M
Total Equity $3.3B $3.6B $3.1B $3B $3.2B
 
Total Liabilities and Equity $15.7B $16.3B $15.9B $15.7B $15.5B
Cash and Short Terms $2.5B $1.3B $1.1B $959M $873M
Total Debt $7.9B $7.9B $8.4B $8.3B $8.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $2.1B $2.7B $3B $3B $3.5B
Depreciation & Amoritzation $427M $410M $410M $395M $402M
Stock-Based Compensation $42M $53M $63M $69M $61M
Change in Accounts Receivable $95M -$240M -$461M $64M $34M
Change in Inventories $43M -$450M -$455M $360M $176M
Cash From Operations $2.8B $2.6B $2.3B $3.5B $3.3B
 
Capital Expenditures $236M $296M $412M $455M $437M
Cash Acquisitions $1M -$731M $276M $7M $280M
Cash From Investing -$214M -$984M -$110M -$403M -$144M
 
Dividends Paid (Ex Special Dividend) -$1.4B -$1.5B -$1.5B -$1.6B -$1.7B
Special Dividend Paid
Long-Term Debt Issued -- $90M $593M $1.4B $1.6B
Long-Term Debt Repaid -$4M -$351M -$1.1B -$679M -$1.9B
Repurchase of Common Stock -$706M -$1B -$1.8B -$1.5B -$1.5B
Other Financing Activities -$26M -$10M -$13M -$14M -$38M
Cash From Financing -$2B -$2.6B -$3B -$2.8B -$3.2B
 
Beginning Cash (CF) $2B $2.6B $1.5B $708M $1.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $544M -$991M -$762M $354M -$52M
Ending Cash (CF) $2.6B $1.5B $708M $1.1B $948M
 
Levered Free Cash Flow $2.6B $2.3B $1.9B $3.1B $2.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $671M $662M $714M $819M $700M
Depreciation & Amoritzation $100M $106M $99M $97M $95M
Stock-Based Compensation $11M $16M $17M $15M $16M
Change in Accounts Receivable -$192M -$301M -$17M -$139M -$120M
Change in Inventories -$122M -$207M $64M -$12M -$37M
Cash From Operations $609M $323M $728M $589M $592M
 
Capital Expenditures $68M $74M $113M $95M $96M
Cash Acquisitions -- -$2M -$3M -$57M $2M
Cash From Investing -$65M -$73M -$111M -$152M -$92M
 
Dividends Paid (Ex Special Dividend) -$361M -$382M -$400M -$419M -$441M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $357M -- -- --
Long-Term Debt Repaid -- -$656M -$138M -$700M --
Repurchase of Common Stock -$250M -$375M -$375M -$375M -$375M
Other Financing Activities -$9M -$13M -$14M -$23M -$18M
Cash From Financing -$594M -$489M -$185M -$524M -$588M
 
Beginning Cash (CF) $2.6B $1.5B $708M $1.1B $948M
Foreign Exchange Rate Adjustment -$30M $8M $3M -$19M $13M
Additions / Reductions -$50M -$239M $432M -$87M -$88M
Ending Cash (CF) $2.5B $1.3B $1.1B $959M $873M
 
Levered Free Cash Flow $541M $249M $615M $494M $496M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $2.2B $2.7B $3.1B $3.1B $3.4B
Depreciation & Amoritzation $423M $416M $403M $393M $400M
Stock-Based Compensation $44M $58M $64M $67M $62M
Change in Accounts Receivable -$107M -$349M -$177M -$58M $53M
Change in Inventories -$31M -$535M -$184M $284M $151M
Cash From Operations $2.8B $2.3B $2.8B $3.4B $3.3B
 
Capital Expenditures $244M $302M $451M $437M $438M
Cash Acquisitions -- -$733M $275M -$47M $339M
Cash From Investing -$226M -$992M -$148M -$444M -$84M
 
Dividends Paid (Ex Special Dividend) -$1.4B -$1.5B -$1.6B -$1.6B -$1.7B
Special Dividend Paid
Long-Term Debt Issued -- $447M -- -- --
Long-Term Debt Repaid -$4M -$1B -$595M -$1.2B -$1.2B
Repurchase of Common Stock -$250M -$1.1B -$1.8B -$1.5B -$1.5B
Other Financing Activities -$19M -$14M -$14M -$23M -$33M
Cash From Financing -$1.6B -$2.5B -$2.7B -$3.1B -$3.3B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $980M -$1.2B -$91M -$165M -$53M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.6B $2B $2.3B $3B $2.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $671M $662M $714M $819M $700M
Depreciation & Amoritzation $100M $106M $99M $97M $95M
Stock-Based Compensation $11M $16M $17M $15M $16M
Change in Accounts Receivable -$192M -$301M -$17M -$139M -$120M
Change in Inventories -$122M -$207M $64M -$12M -$37M
Cash From Operations $609M $323M $728M $589M $592M
 
Capital Expenditures $68M $74M $113M $95M $96M
Cash Acquisitions -- -$2M -$3M -$57M $2M
Cash From Investing -$65M -$73M -$111M -$152M -$92M
 
Dividends Paid (Ex Special Dividend) -$361M -$382M -$400M -$419M -$441M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $357M -- -- --
Long-Term Debt Repaid -- -$656M -$138M -$700M --
Repurchase of Common Stock -$250M -$375M -$375M -$375M -$375M
Other Financing Activities -$9M -$13M -$14M -$23M -$18M
Cash From Financing -$594M -$489M -$185M -$524M -$588M
 
Beginning Cash (CF) $2.6B $1.5B $708M $1.1B $948M
Foreign Exchange Rate Adjustment -$30M $8M $3M -$19M $13M
Additions / Reductions -$50M -$239M $432M -$87M -$88M
Ending Cash (CF) $2.5B $1.3B $1.1B $959M $873M
 
Levered Free Cash Flow $541M $249M $615M $494M $496M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 8

Regencell Bioscience Holdings [RGC] is up 28.63% over the past day.

Buy
52
SRPT alert for May 8

Sarepta Therapeutics [SRPT] is up 0.35% over the past day.

Buy
74
LIVN alert for May 8

LivaNova PLC [LIVN] is down 0% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock